Keraglo-AD Lotion contains Ketoconazole 2% w/v, an antifungal agent belonging to the imidazole class, indicated for the treatment of various fungal infections of the skin. Ketoconazole exerts its therapeutic effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Keraglo-AD Lotion is primarily used in the management of dermatophytosis, candidiasis, and pityriasis versicolor, as well as seborrheic dermatitis characterized by scaling, redness, and itching. The topical formulation allows for targeted application, minimizing systemic absorption and associated side effects. It is recommended to apply the lotion to the affected area once or twice daily, depending on the severity of the infection, and to continue treatment for at least two weeks or as directed by a healthcare professional to prevent recurrence. Common adverse effects are generally mild and may include local irritation, burning sensation, or dryness at the site of application. Keraglo-AD Lotion should be used with caution in patients with known hypersensitivity to ketoconazole or any excipients. It is contraindicated in open wounds or mucosal surfaces. Consultation with a healthcare provider is advised before initiating therapy to ensure appropriate diagnosis and treatment.